Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Serum Market
Market Size in USD Billion
CAGR :
%
USD
1.57 Billion
USD
3.37 Billion
2024
2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD
1.57 Billion
Market Size (Forecast Year)
USD
3.37 Billion
CAGR
%
Major Markets Players
Thermo Fisher Scientific
Merck KGaA
Cytiva
BioTechne
Atlas Biologicals
Global Serum Market Segmentation, By Type (Bovine Serum, FBS, and Other), Inactivation Technique (Heat Inactivated and Non-Heat Inactivated), Application (Biological Products, Research, Cell Culture, Biopharmaceutical Drugs, Vaccine Products, Diagnostic Products, and Others), End User (Biopharmaceutical and Biotechnology Industry, Diagnostics Laboratories, Research Laboratories, and Academic Research), Sales Channel (Direct Channel and Distribution Channel) - Industry Trends and Forecast to 2032
The global serum market was valued at USD 1.57 billion in 2024 and is expected to reach USD 3.37 billion by 2032
During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 10.00%, primarily driven by the increasing demand for diagnostic and therapeutic application.
This growth is driven by factors such as rising health expenditure, increasing prevalence of chronic disease, and advancements in technology
Serum Market Analysis
Serum products are vital in various healthcare applications, including diagnostics, therapeutic treatments, and research. They are essential in the preparation of vaccines, biologics, and in-vitro diagnostic assays, as well as being used for the cultivation of cells in biotechnology and regenerative medicine
The demand for serum is primarily driven by the increasing prevalence of chronic diseases, rising healthcare needs, and advancements in biotechnology and pharmaceutical research. The growing adoption of serum in clinical trials and the rise in stem cell therapies are significantly boosting the market
North America is one of the dominant regions in the global serum market, driven by its advanced healthcare infrastructure, high spending on research and development, and robust pharmaceutical and biotechnology sectors. The demand for serum-based products in diagnostics and therapeutic applications is particularly high in the U.S. due to the country's leading role in medical research and healthcare innovation
Globally, serum products rank as one of the most critical components in laboratory testing, research, and treatment development. With the increasing focus on personalized medicine and the expansion of clinical trials, the role of serum in ensuring effective diagnostic outcomes and therapeutic solutions continues to grow
Report Scope and Serum Market Segmentation
Attributes
Serum Key Market Insights
Segments Covered
By Type: Bovine Serum, FBS, and Other
By Inactivation Technique: Heat Inactivated and Non-Heat Inactivated
By Application: Biological Products, Research, Cell Culture, Biopharmaceutical Drugs, Vaccine Products, Diagnostic Products, and Others
By End User: Biopharmaceutical and Biotechnology Industry, Diagnostics Laboratories, Research Laboratories, and Academic Research
By Sales Channel: Direct Channel and Distribution Channel
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Serum Market Trends
“Increasing Adoption of Automation and Artificial Intelligence (AI)”
One prominent trend in the global serum market is the growing adoption of automation and artificial intelligence (AI) technologies
These advanced technologies enhance the efficiency and accuracy of serum production, processing, and testing by automating repetitive tasks, reducing human error, and improving throughput in laboratories and manufacturing facilities
For instance, AI-powered systems are being used for serum quality control, where machine learning algorithms analyze large datasets to predict and detect potential issues, ensuring consistent and high-quality serum products
Automation also streamlines the serum-based diagnostic processes, reducing turnaround time for results and improving the speed of diagnostic testing, which is crucial for rapid patient care
This trend is revolutionizing the serum market, optimizing production processes, increasing scalability, and improving the overall quality and accessibility of serum products across various healthcare sectors
Serum Market Dynamics
Driver
“Growing Demand Due to Prevalence of Chronic Diseases”
The rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer is significantly driving the demand for serum products globally
As the global population ages and the incidence of these diseases increases, the need for serum-based diagnostic tests and therapeutic solutions grows, with serum being a vital component in detecting and managing these conditions
Serum is crucial for diagnosing infections, monitoring disease progression, and detecting biomarkers in patients with chronic conditions, making it an indispensable tool in healthcare
The increasing focus on personalized medicine, where serum biomarkers are used to tailor treatments to individual patients, further contributes to the expanding demand for high-quality serum products
With the growing need for early disease detection and better treatment options, the demand for serum-based diagnostics is expected to rise significantly, ensuring improved health outcomes and more efficient healthcare delivery
For instance,
In 2023, according to a study published in the Journal of Clinical Diagnostics, the rising prevalence of diabetes worldwide, particularly in individuals aged 40 and above, has created a significant demand for serum-based tests to manage blood glucose levels and detect diabetic complications. This trend is driving the global serum market
In 2024, a report by the World Health Organization noted that cardiovascular diseases are the leading cause of death globally, leading to increased demand for serum-based testing to monitor cholesterol, lipids, and other cardiovascular markers
The growing prevalence of chronic diseases and the increasing demand for personalized medicine are key factors driving the global serum market, enhancing diagnostic accuracy and improving patient care outcomes
Opportunity
“Advancements in AI and Automation in Serum Production”
The integration of artificial intelligence (AI) and automation into serum production processes is revolutionizing the market by improving efficiency, quality control, and scalability
AI-powered systems can monitor and predict the quality of serum batches in real-time, ensuring consistent and high-quality products, reducing errors, and enhancing the overall manufacturing process
Automation streamlines the processing and packaging of serum products, lowering production costs and increasing output, making serum products more affordable and accessible to healthcare providers globally
For instance,
In January 2025, according to an article published in The Journal of Biotechnology, AI algorithms are being increasingly employed to monitor serum quality during the manufacturing process, helping to predict batch inconsistencies and prevent product recalls. These innovations are expected to drive growth in the global serum market
In November 2023, Automation Today reported that automated serum processing systems are improving the speed and accuracy of serum production, which is enabling greater scalability and meeting the rising global demand for serum-based diagnostics and therapeutics
The integration of AI and automation in serum production is enhancing efficiency, quality, and scalability, driving growth and accessibility in the global serum market
Restraint/Challenge
“High Production Costs and Regulatory Hurdles”
The high cost of serum production and stringent regulatory requirements pose significant challenges to the market, especially for small-scale producers and emerging market players
Serum production, particularly from human sources, involves complex processes and strict adherence to Good Manufacturing Practices (GMP), making it a resource-intensive and costly operation
Regulatory compliance for serum-based products, including extensive testing and certification, adds additional time and costs to product development and distribution, which may delay market entry and limit supply
For instance,
In December 2024, according to an article published by Biopharma News, the cost of producing serum-based diagnostic tests continues to rise due to the complexities of sourcing and processing raw materials, along with the regulatory barriers that must be overcome to ensure safety and efficacy. This challenge affects pricing and accessibility in certain regions, especially in developing countries
These factors create a barrier to market penetration, particularly in regions with limited access to advanced manufacturing capabilities, thereby hindering the overall growth of the global serum market
Serum Market Scope
The market is segmented on the basis of type, inactivation technique, application, end user, and sales channel.
Segmentation
Sub-Segmentation
By Type
Bovine Serum
FBS
Other
By Inactivation Technique
Heat Inactivated
Non-Heat Inactivated
By Application
Biological Products
Research
Cell Culture
Biopharmaceutical Drugs
Vaccine Products
Diagnostic Products
Others
By End User
Biopharmaceutical and Biotechnology Industry
Diagnostics Laboratories
Research Laboratories
Academic Research
By Sales Channel
Direct Channel
Distribution Channel
Serum Market Regional Analysis
“North America is the Dominant Region in the Serum Market”
North America leads the global serum market, driven by its advanced healthcare infrastructure, strong regulatory frameworks, and high adoption of state-of-the-art diagnostic technologies
U.S. holds a significant market share, fuelled by the growing demand for serum-based diagnostic tests, particularly in managing chronic diseases such as diabetes, cardiovascular conditions, and cancer. The presence of major serum producers and well-established healthcare reimbursement policies strengthens the region's market position
In addition, the increasing prevalence of chronic diseases and the continuous advancements in personalized medicine are driving the demand for high-quality serum products
The strong investment in research and development by leading pharmaceutical and biotechnology companies ensures continuous innovation, further solidifying North America's dominance in the global serum market
“Asia-Pacific is Projected to Register the Highest Growth Rate”
Asia-Pacific is expected to experience the highest growth rate in the global serum market, supported by rapid advancements in healthcare infrastructure, growing awareness about disease prevention, and increasing healthcare spending
Countries such as China, India, and Japan are emerging as key markets due to their large populations, rising prevalence of chronic diseases, and improvements in healthcare accessibility
Japan is at the forefront, with its advanced healthcare systems and robust demand for serum-based diagnostic tests, particularly in managing conditions such as diabetes and cardiovascular diseases
China and India, with their expanding healthcare sectors and increasing cases of chronic conditions, are seeing heightened government and private sector investments in diagnostic infrastructure, making them key contributors to the growth of the global serum market
Serum Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
In January 2025, Thermo Fisher Scientific announced the launch of its next-generation serum testing platform, designed to enhance the accuracy and efficiency of serum-based diagnostics. The new platform integrates advanced AI algorithms for real-time analysis of biomarkers, providing faster and more reliable results for managing chronic diseases such as diabetes and cardiovascular conditions. The platform also offers customizable testing options for personalized medicine, supporting more tailored treatment regimens for patients
In December 2024, Abbott Laboratories unveiled a new line of serum-based diagnostic assays, focusing on the early detection of multiple chronic conditions, including liver disease and cardiovascular disorders. These tests are designed to provide high sensitivity and specificity, ensuring early diagnosis and better treatment outcomes. Abbott’s innovative solutions are expected to drive significant growth in the global serum market, especially in regions with rising healthcare demands
In November 2024, Siemens Healthineers introduced its updated serum biomarker testing system, which improves the speed and accuracy of serum analysis for oncology and infectious diseases. The system incorporates a fully automated workflow, reducing human error and enhancing laboratory productivity. This development is poised to revolutionize serum testing in clinical laboratories and hospitals, ensuring quicker diagnostic decisions for patients globally
In September 2024, Roche Diagnostics launched a new serum-based test for cardiovascular health monitoring. The test measures multiple biomarkers simultaneously, allowing healthcare providers to better manage heart disease and related conditions. This advancement underscores the growing importance of serum diagnostics in the early detection and management of chronic conditions, further fuelling the expansion of the serum market
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future